GlassScriptPhysician profile
Andre Victor Coombs
NPI 1639581903
$7,041.22
in general payments reported to CMS, 2019-2025
10 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $625 · 2021: $250 · 2022: $3,391 · 2023: $1,173 · 2024: $458 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,774.92 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,900.01 | 2022-2024 | Advantagerib, Sternalock Blu System |
| Merck Sharp & Dohme LLC | $1,250.00 | 2021-2025 | |
| Medical Device Business Services, INC. | $625.24 | 2020 | |
| Tela Bio, INC. | $408.17 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Atricure, INC. | $267.01 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Acera Surgical, INC. | $161.08 | 2023 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $153.83 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $123.50 | 2023 | Harmonic, Evarrest |
| Polynovo North America LLC | $90.89 | 2025 | Novosorb Btm |
| Access Pro Medical, LLC | $61.49 | 2025 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Coombs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.